Nya chefer på Bayer när ny organisation införs i Sverige

Läkemedelsjätten Bayer har utsett Karin Eidolf till Sverigechef för sin läkemedelsdivision, samtidigt som Martin Stagmo blir ny medicinsk chef i Sverige.

Eli Lilly to build a USD 2.5-billion plant in Germany

US-based Eli Lilly is planning a huge investment of USD 2.5 billion, equivalent to around SEK 26.5 billion, in a new production facility in Alzey, Germany.

Study: Vaccination linked to lower risk of post-COVID

The risk of developing post-COVID after a COVID infection was reduced in vaccinated people, according to a new study from the University of Gothenburg.

Suing the company – for NOT developing a new HIV drug

Was Gilead putting a steady flow of profits from its cash cow ahead of developing a new and safer drug? According to a large number of US HIV patients in a lega...

Tirzepatide approved for obesity by the FDA – to be branded as Zepbound

Diabetes drug tirzepatide has now also been approved in the US for treating obesity.

Improve your secondary battery manufacturing

SMC provides a large portfolio of products specially designed for secondary battery industry.

Hon blir ny medicinsk chef på Synact Pharma

Synact Pharma, som bland annat utvecklar behandlingar för reumatiska sjukdomar, har utsett Kirsten Harting till ny Chief Medical Officer.

Webinar: How to Plan And Analyze a Real-World Evidence Study

This webinar is for drug developers who want to understand the basic ideas of analyzing an RWE study, as well as avoiding the most common pitfalls.

Mizarra Business Management

Han är ny på Capitainer

Solnaföretaget Capitainer har anställt Johan Olausson som applikationsspecialist.

Studie med läkemedel mot nervsmärta startar

Lundaföretaget Pharmnovo påbörjar nu kliniska studier med sin läkemedelskandidat mot neuropatisk smärta.

Samuel Lagercrantz: The government’s performance in healthcare and life sciences so far

Since the change of government in Sweden, developments in the healthcare sector have shown promising signs, but the outlook in life sciences is less promising, ...

Hello Angelica Loskog!

Life Science Sweden would like to know more about Angelica Loskog and interviews her about her life as a researcher.

Forskningsentreprenörens satsning ska förenkla forskning.

Cancerforskaren Sara Mangsbo vill förenkla det administrativa forskningsarbetet

Søren Bregenholt omvald som ordförande i MVA

Under Medicon Valley Alliance årsstämma fick styrelsen förnyat förtroende och valdes om.

Novo Nordisk to invest billions in Danish manufacturing facilities

Danish pharmaceutical giant Novo Nordisk is investing DKK 42 billion, equivalent to around SEK 65 billion/EUR 5.6 billion, in its manufacturing facilities in Ka...

Automated dispensing of liquids

Have a look at how you can do easier and faster dispensing on the fly adapted to your needs

High-tech companies are increasingly focusing on health

Tech companies have been taking an interest in healthcare for many years, and this interest seems to be increasing. “It’s not a sudden shift in trend, it’s more...

Heidi Stensmyren is eager for new challenges in the biotech industry

management roles,” she says.

SDS Life Science rekryterar erfaren IT-manager

Med sin expertis och erfarenhet som IT- arkitekt blir Jan Broman SDS-gruppens senaste tillskott i rollen som IT-manager.

Charlotta Gummeson leaves Sahlgrenska Science Park – “It feels sad and exciting at the same time”

With mixed emotions, Charlotta Gummeson will leave her position as CEO of Sahlgrenska Science Park in October. “It feels sad and exciting at the same time. I’ve...

Anna Törner: The clinical trial – Periscope to reality

What happens to the patients in the clinical trial is not very interesting, writes Anna Törner in a column.

“We need to keep investing in research and innovation”

Jenni Nordborg has worked for just over four years to highlight life science in Sweden. Her mandate as national coordinator ends in December 2022. ““Life scienc...

The first drugs to slow down Alzheimer’s – but what does it mean for patients?

New treatments for early Alzheimer’s are bringing hope to thousands of patients and their families. The question is, who will get the treatment, how will the ri...